Plasma fibroblast activation protein is decreased in acute heart failure despite cardiac tissue upregulation
Abstract Background Cardiac fibroblast activation protein (FAP) has an emerging role in heart failure (HF). A paradoxical reduction in its levels in pathological conditions associated with acute processes has been observed. We aimed to identify FAP cardiac tissue expression and its relationship with...
Main Authors: | Marta Delgado-Arija, Patricia Genovés, Lorena Pérez-Carrillo, Irene González-Torrent, Isaac Giménez-Escamilla, Luis Martínez-Dolz, Manuel Portolés, Estefanía Tarazón, Esther Roselló-Lletí |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-04900-w |
Similar Items
-
Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure
by: Isaac Giménez-Escamilla, et al.
Published: (2024-02-01) -
Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study
by: Lorena Pérez-Carrillo, et al.
Published: (2022-09-01) -
Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure
by: Lorena Pérez-Carrillo, et al.
Published: (2022-01-01) -
Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
by: Yan Cui, et al.
Published: (2023-09-01) -
Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support
by: Meryem Ezzitouny, et al.
Published: (2021-10-01)